B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.Bundi CK Mu├▒oz O Kibwana E Bellamy D Stockdale L Barrett JR McHugh K Mtaka I Kalinga W Kimani D Nyamako L Keter K Ogwang R Hill AVS Bejon P Hamaluba M Silk SE Minassian AM Draper SJ Olotu AI Kapulu MC Ewer KJ Nielsen CM
Front Immunol, (2026). 17:1743327

Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons.Ogwang R Adan M Bejon P Kapulu MC
Front Immunol, (2025). 16:1672945

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.Kibwana E Bundi C Kimani D Nyamako L Keter K Mutiso A Ogwang R Bellamy D Rapi K Bajer A Provstgaard-Morys S Stockdale L Munoz O Datoo MS Lawrie A Ramos-Lopez F Roberts R Hamaluba M Hill AVS Bejon P Ewer KJ Kapulu M
Front Immunol, (2025). 16:1620365

Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.Bundi C Bellamy D Kibwana E Nyamako L Ogwang R Keter K Kimani D Salman AM Provstgaard-Morys S Stockdale L Hill AVS Bejon P Olotu A Hamaluba M Ewer KJ Kapulu MC
Front Immunol, (2025). 16:1620366

Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.Ogwang R Murugu L Nkumama IN Nyamako L Kai O Mwai K Murungi L Idro R Bejon P Tuju J Kinyanjui SM Osier FHA
Front Immunol, (2024). 15:1360220

Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.Kapulu MC Muthumbi E Otieno E Rossi O Ferruzzi P Necchi F Acquaviva A Martin LB Orindi B Mwai K Kibet H Mwanzu A Bigogo GM Verani JR Mbae C Nyundo C Agoti CN Nakakana UN Conti V Bejon P Kariuki S Scott JAG Micoli F Podda A
Front Immunol, (2024). 15:1340425

Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.Kapulu MC Nakakana U Scire AS Sarakinou E Conti V Rossi O Acquaviva A Necchi F Obiero CW Martin LB Bejon P Njuguna P Micoli F Podda A
Front Immunol, (2022). 13:971866

Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study.Kimingi HW Kinyua AW Achieng NA Wambui KM Mwangi S Nguti R Kivisi CA Jensen ATR Bejon P Kapulu MC Abdi AI Kinyanjui SM Chmi-Sika Study Team
Front Immunol, (2022). 13:894770

Plasmodium falciparum-Specific Memory B-Cell and Antibody Responses Are Associated With Immunity in Children Living in an Endemic Area of Kenya.Jahnmatz P Nyabundi D Sundling C Widman L Mwacharo J Musyoki J Otieno E Ahlborg N Bejon P Ndungu FM Farnert A
Front Immunol, (2022). 13:799306

Antibody Responses to Crude Gametocyte Extract Predict Plasmodium falciparum Gametocyte Carriage in Kenya.Omondi BR Muthui MK Muasya WI Orindi B Mwakubambanya RS Bousema T Drakeley C Marsh K Bejon P Kapulu MC
Front Immunol, (2020). 11:609474

Corrigendum: Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African falciparum Context: A Systematic Review and Meta-Analysis.Muthui MK Kamau A Bousema T Blagborough AM Bejon P Kapulu MC
Front Immunol, (2020). 11:389

Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African falciparum Context: A Systematic Review and Meta-Analysis.Muthui MK Kamau A Bousema T Blagborough AM Bejon P Kapulu MC
Front Immunol, (2019). 10:2480

KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.Kamuyu G Tuju J Kimathi R Mwai K Mburu J Kibinge N Chong Kwan M Hawkings S Yaa R Chepsat E Njunge JM Chege T Guleid F Rosenkranz M Kariuki CK Frank R Kinyanjui SM Murungi LM Bejon P Farnert A Tetteh KKA Beeson JG Conway DJ Marsh K Rayner JC Osier FHA
Front Immunol, (2018). 9:2866

A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country.Obiero CW Ndiaye AGW Scire AS Kaunyangi BM Marchetti E Gone AM Schutte LD Riccucci D Auerbach J Saul A Martin LB Bejon P Njuguna P Podda A
Front Immunol, (2017). 8:1884